𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dose reduction of epoetin-alpha in the prevention of chemotherapy-induced anaemia

✍ Scribed by François Lüthi; Miklos Pless; Serge Leyvraz; Beat Biedermann; Emilie Müller; Richard Hermann; Christian Monnerat

Publisher
Springer-Verlag
Year
2009
Tongue
English
Weight
133 KB
Volume
18
Category
Article
ISSN
0941-4355

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Establishing the dose of the oral NK1 an
Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting
✍ Sant P. Chawla; Steven M. Grunberg; Richard J. Gralla; Paul J. Hesketh; Cindy Ri 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

## Abstract ## BACKGROUND The neurokinin‐1 antagonist aprepitant (EMEND™; Merck Research Laboratories, West Point, PA) has been shown to reduce chemotherapy‐induced nausea and vomiting when it is given with a 5‐hydroxytryptamine‐3 receptor antagonist and dexamethasone. The current study sought to

High versus low dose granisetron, a sele
High versus low dose granisetron, a selective 5HT3antagonist, for the prevention of chemotherapy-induced nausea and vomiting
✍ H. C. Falkson; C. I. Falkson; G. Falkson 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 173 KB

Fifty six patients, with histologically confirmed cancer, who received highly emetogenic chemotherapy, were entered on a randomized double blind, low versus high dose, study of granisetron, a 5HT3 receptor antagonist. A single dose of intravenous granisetron protected the majority of patients from n